Stock futures exhibited mixed performance on Tuesday as investors assessed fresh comments from President Donald Trump on ...

Hims stock plunged Tuesday after the compounding pharmacy issued a bullish outlook that still includes knockoff versions of ...

Stock in Hims & Hers Health was bound to tumble once it [could no longer sell]( ...

Hims & Hers expects revenue from its weight loss business to soar in 2025, even though a recent FDA move could make it ...